If you’re over 30 and have battled your weight for years, you know how demoralising it can be. The scales won’t budge, energy dips, and suddenly your doctor mentions words like “pre‑diabetes,” “blood pressure,” or “fertility challenges.” You’ve tried every diet, you’ve rejoined the gym more times than you can count, and you may have even undergone sleeve gastrectomy – only to watch the kilos creep back. As a doctor practising in Australia, I see this heartbreak daily. But there is a breakthrough that is changing the narrative: semaglutide.
Semaglutide is a GLP‑1 receptor agonist – a medication that mimics a natural hormone called glucagon‑like peptide‑1. It works in three powerful ways: it reduces appetite by acting on the brain’s hunger centres, it slows stomach emptying so you feel fuller longer, and it improves your body’s insulin sensitivity. Originally developed for type 2 diabetes, its weight‑loss effects were so remarkable that a dedicated formulation (Wegovy) is now TGA‑approved for chronic weight management in adults.
| Brand | Form | Approved Indication | Typical Dosing Schedule |
|---|---|---|---|
| Wegovy | Weekly injection | Chronic weight management (BMI ≥30 or ≥27 with co‑morbidities) | Escalating doses up to 2.4 mg weekly |
| Ozempic | Weekly injection | Type 2 diabetes; often used off‑label for weight loss | 0.25 mg to 1.0 mg weekly |
| Rybelsus | Daily oral tablet | Type 2 diabetes | 3 mg to 14 mg daily |
While Ozempic is widely recognised, Wegovy is the only TGA‑registered option specifically for weight loss. Supply has improved significantly, and many Australian GPs can now prescribe it via private prescription.
Obesity in teenagers is a growing crisis, setting them up for a lifetime of health struggles. The STEP TEENS trial showed that once‑weekly semaglutide, combined with lifestyle changes, reduced BMI by an average of 16% in adolescents aged 12 to <18. While not yet TGA‑approved for this age group in Australia, the evidence is compelling. As a specialist, I discuss this option with families when conventional methods have failed and significant obesity‑related complications are present. Early intervention can spare your child from a future of joint pain, bullying, and metabolic disease.
One common fear is that losing weight quickly will leave you with excess loose skin or muscle loss. The solution is strategic exercise – and semaglutide makes it easier by giving you back the energy to move. Use this simple guide:
| Goal | Type of Exercise | Frequency |
|---|---|---|
| Preserve muscle mass | Resistance training (weights, bands, bodyweight) | 2–3 times per week |
| Boost cardiovascular health | Moderate cardio (brisk walking, cycling, swimming) | 150 minutes per week |
| Enhance flexibility & recovery | Yoga, stretching | 2–3 sessions per week |
Semaglutide reduces hunger, but your body still needs protein. Pair your workouts with a high‑protein diet to build strength while shedding fat.
After massive weight loss – whether through diet, bariatric surgery, or medication – many patients desire body contouring surgery to remove excess skin. Semaglutide can play a role here, but with an essential caveat. Because GLP‑1 agonists delay gastric emptying, they may increase the risk of aspiration during anaesthesia. All major surgical bodies in Australia now recommend stopping semaglutide at least one week before elective surgery (often up to two weeks for the higher Wegovy dose). Communicate clearly with your plastic surgeon and anaesthetist. Once you have recovered and are eating normally, resuming semaglutide can help you maintain your new contours and prevent weight regain that would compromise your surgical results.
The cruelest truth about weight loss is that your body fights to regain the kilos – hormonal changes persist for years. Semaglutide is a long‑term maintenance tool, not a quick fix. The STEP 5 study demonstrated that continuing Wegovy 2.4 mg for two years led to sustained weight loss of around 15%, while those who stopped regained a significant portion. If you’ve lost weight and are terrified of undoing your hard work, a maintenance dose of semaglutide can be the difference between permanent transformation and another heartbreaking cycle.
For many Australians, sleeve gastrectomy was the lifeline they needed. Yet I frequently see patients 2–5 years post‑surgery who are struggling with regain. Semaglutide is an outstanding adjunctive treatment. It complements the reduced stomach capacity by curbing appetite and improving satiety. Studies confirm that adding a GLP‑1 agonist after bariatric surgery can deliver additional weight loss and better glycaemic control. If your sleeve has “stretched” or old habits have crept back, semaglutide can help you get back on track without a revision procedure.
Infertility is often a hidden wound of obesity. Excess weight disrupts ovulation, reduces egg quality, and lowers IVF success rates. Before embarking on costly IVF cycles, many fertility specialists now recommend pre‑conception weight loss. Semaglutide can help you shed 10–15% of your body weight, potentially restoring natural ovulation or dramatically improving your response to fertility medications. Vital safety note: semaglutide must be discontinued at least two months before attempting conception or starting an IVF stimulation cycle, due to unknown risks to the developing foetus. Use it as a bridge to a healthier pregnancy – not during one.
Even if you are not pursuing IVF, planning a pregnancy after 30 with obesity carries increased risks: gestational diabetes, hypertension, caesarean delivery, and large‑for‑gestational‑age babies. Achieving a healthier weight with semaglutide before you conceive can dramatically reduce these risks. Work with your GP to set a target, then allow a washout period. The benefits for both mother and child are clear.
Imagine waking up with energy, fitting into clothes you’ve held onto for years, and finally breaking free from the shame and frustration. Semaglutide is not a miracle injection – it requires your commitment to whole‑food eating and movement – but it can be the catalyst that makes those efforts finally feel effective. Whether you are a parent worried about your teenager, a post‑bariatric patient feeling defeated, or someone longing for a baby, this medication could rewrite your story.
Semaglutide is a prescription‑only medicine. It is not suitable for everyone; side effects like nausea, vomiting, or pancreatitis require medical supervision. Book an appointment with your Australian GP to discuss whether Wegovy (or another semaglutide brand) is appropriate for you. Bring this article, ask the hard questions, and start the conversation that could transform your health. Don’t wait another month – your transformation could begin today.
This article reflects the clinical experience and opinion of the author and does not replace individual medical advice. Always consult a registered health professional before starting any new medication.